126 related articles for article (PubMed ID: 18091733)
1. Blood pressure variability: the challenge of variation.
Marshall TP
Am J Hypertens; 2008 Jan; 21(1):3-4. PubMed ID: 18091733
[No Abstract] [Full Text] [Related]
2. Blood pressure variability causes spurious identification of hypertension in clinical studies: a computer simulation study.
Turner MJ; van Schalkwyk JM
Am J Hypertens; 2008 Jan; 21(1):85-91. PubMed ID: 18091749
[TBL] [Abstract][Full Text] [Related]
3. Carryover effects after cessation of drug treatment: trophies or dreams?
Lumley T; Rice KM; Psaty BM
Am J Hypertens; 2008 Jan; 21(1):14-6. PubMed ID: 18091738
[TBL] [Abstract][Full Text] [Related]
4. Lowering blood pressure in acute stroke: the SCAST trial.
Hankey GJ
Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
[No Abstract] [Full Text] [Related]
5. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.
Saxby BK; Harrington F; Wesnes KA; McKeith IG; Ford GA
Neurology; 2008 May; 70(19 Pt 2):1858-66. PubMed ID: 18458219
[TBL] [Abstract][Full Text] [Related]
6. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
Bramlage P; Schönrock E; Odoj P; Wolf WP; Funken C
MMW Fortschr Med; 2008 Feb; 150(6):40. PubMed ID: 18323344
[No Abstract] [Full Text] [Related]
7. [Evaluation of antihypertensive effect of angiotensin II receptor blockers in patients with essential hypertension by self-measured home blood pressure--HACARARE 300 study].
Msanobu T;
Nihon Rinsho; 2009 Oct; 67(10):2013-20. PubMed ID: 19860206
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
9. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
10. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
[No Abstract] [Full Text] [Related]
11. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
Sarzani R; Dessì-Fulgheri P
J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
[No Abstract] [Full Text] [Related]
13. [In high risk patients also treat high normal blood pressure values!].
Düsing R
MMW Fortschr Med; 2006 Mar; 148(13):5. PubMed ID: 16642693
[No Abstract] [Full Text] [Related]
14. Plasma renin activity for predicting antihypertensive drug efficacy.
Blumenfeld JD
Am J Hypertens; 2008 Jan; 21(1):5-6. PubMed ID: 18091734
[No Abstract] [Full Text] [Related]
15. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
Suzuki H; Kanno Y;
Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560
[TBL] [Abstract][Full Text] [Related]
16. [Successful high dosage fixed combination. 7 of 10 patients achieve target blood pressure].
MMW Fortschr Med; 2006 Nov; 148(45):59. PubMed ID: 17615754
[No Abstract] [Full Text] [Related]
17. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
Shigenaga A; Tamura K; Dejima T; Ozawa M; Wakui H; Masuda S; Azuma K; Tsurumi-Ikeya Y; Mitsuhashi H; Okano Y; Kokuho T; Sugano T; Ishigami T; Toya Y; Uchino K; Tokita Y; Umemura S
Nephron Clin Pract; 2009; 112(1):c31-40. PubMed ID: 19342867
[TBL] [Abstract][Full Text] [Related]
18. ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial.
Ogihara T; Fujimoto A; Nakao K; Saruta T;
Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1195-201. PubMed ID: 18939907
[TBL] [Abstract][Full Text] [Related]
19. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
[No Abstract] [Full Text] [Related]
20. Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.
Parati G; Ochoa JE; Ramos C; Hoshide S; Lonati L; Bilo G
Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):301-13. PubMed ID: 20921092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
